,35 Deletion of the Irf3 or Ifnar gene afforded a near complete survival postmyocardial infarction, a finding that, if replicated in independent experiments, would render IRF3 and its receptors as very attractive therapeutic targets in myocardial infarction.35 This evidence concerns the gene IFNAR1 and myocardial infarction.